CMS Launches 2026 Drug Acquisition Cost Survey for Medicare OPPS Hospitals
CMS will conduct a drug acquisition cost survey in early 2026 to collect data from hospitals under the Medicare OPPS, informing 2027 outpatient payment policies.
CMS will conduct a drug acquisition cost survey in early 2026 to collect data from hospitals under the Medicare OPPS, informing 2027 outpatient payment policies.
Key updates on Social Security benefits and Medicare costs for 2026, including COLA increases, enrollment details, tax implications, and program solvency.
CMS introduces the ACCESS Model to enhance chronic care for Medicare beneficiaries using digital health tools and outcome-based payment models starting in 2026.
CMS issues proposed 2027 updates to Medicare Advantage, Part D, risk adjustment, and reporting rules, seeking stakeholder input on quality measures and program improvements.
Medicare Advantage plans see rising enrollment amid care access and cost challenges for providers and beneficiaries, prompting regulatory scrutiny and legislative proposals.
CMS reveals new 2027 price caps for 15 Medicare Part D drugs, projected to save billions federally and reduce patient costs under the Inflation Reduction Act negotiations.
Buprenorphine prescriptions for Mainers 65+ rose 70% from 2019 to 2023, signaling increased opioid treatment needs amid population growth. Challenges in Medicare plan access add complexity for older adults.
Explore how Social Security death record errors can jeopardize health insurance and Medicare coverage, impacting patient access and government data integrity.
Medicare Advantage enrollment surges as hospitals report care delays and increased administrative burdens. Explore the impacts on costs, provider networks, and Medicare policy reforms in 2025.
Explore key insights on Rhode Island's 2024 open enrollment, Medicare options for seniors, and the impact of potential subsidy changes on state health insurance marketplace pricing.